Okami Medical Appoints Rhonda Robb as President and CEO

January 8, 2024—Okami Medical Inc. announced the appointment of Rhonda Robb as President and Chief Executive Officer. Okami Medical is a medical device company focused on peripheral vascular interventions, including its low-profile braided occluder (LOBO) system.

According to the company, Robb has more than 25 years of leadership and commercial experience. Most recently, she served as Chief Operating Officer at Cardiovascular Systems, Inc. Earlier, she served as Vice President and General Manager for Heart Valve Therapies at Medtronic, where she led the transcatheter and surgical heart valve franchises. She also serves on the Board of Directors for 4C Medical.

“I am honored to have the opportunity to lead Okami Medical at this exciting time as we prepare to commercialize our LOBO vascular occlusion system,” commented Robb in the company’s press release. “The team has done a tremendous job of taking the system from the conceptual stage through clinical validation. LOBO is a next-generation technology that is delivering remarkable clinical performance and is uniquely suited to transform and expand the treatment of patients suffering from peripheral vascular conditions.”

Bob Rosenbluth, PhD, Co-Founder and Chairman of the Board of Okami Medical, added, “Rhonda brings a proven track record and a wealth of experience to the company. She shares our commitment and passion for providing patients and physicians with access to advanced technologies that address the numerous challenges in peripheral vascular occlusion. We are thrilled to have her leading the company into the next phase of expansion and growth.”

Okami is the second portfolio company (after Inari Medical, Inc.) of Inceptus Medical LLC, a medical device incubator, noted the press release.